Avadel announces grant of inducement awards under nasdaq listing rule 5635(c)(4)

Dublin, june 16, 2025 (globe newswire) -- avadel pharmaceuticals plc (nasdaq: avdl), a company focused on transforming medicines to transform lives, today announced that the compensation committee of avadel's board of directors approved the grant of non-statutory options to two new employees to purchase 9,600 ordinary shares under avadel's 2021 inducement plan. in addition, effective as of may 13, 2025, the compensation committee of avadel's board of directors approved a grant of non-statutory options to susan rodriguez, avadel's newly appointed chief operating officer, to purchase 300,000 ordinary shares under avadel's 2021 inducement plan.
AVDL Ratings Summary
AVDL Quant Ranking